Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1688, Issue 1, 2004, Pages 33-42

  Nakano, Emi ^a   Williamson, Mike P ^a   Williams, Nick H ^a   Powers, Hilary J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antioxidant; Cardiovascular disease; Citrate; Homocysteine; LDL; Pro oxidant

Indexed keywords

ALBUMIN; ALDEHYDE; ALKADIENE; ANTIOXIDANT; COPPER; CYSTATHIONINE; DJENKOLATE; HOMOCYSTEINE; LIGAND; LOW DENSITY LIPOPROTEIN; OXIDIZING AGENT; RADICAL; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; HUMAN; LIPID OXIDATION; MEASUREMENT; PRIORITY JOURNAL; STIMULATION; SYNTHESIS; TIME;

COPPER; CYSTATHIONINE; CYSTEINE; HOMOCYSTEINE; HOMOCYSTINE; HUMANS; LIPOPROTEINS, LDL; MALONDIALDEHYDE; OXIDATION-REDUCTION; SERUM ALBUMIN; TIME FACTORS;

EID: 1642321899     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.10.005     Document Type: Article

References (57)

1. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., Tishler P.V., Hennekens C.H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
2. Arnesen E., Refsum H., Bonaa K.H., Ueland P.M., Forde O.H., Nordrehaug J.E. Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 24:1995;704-709.
3. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337:1997;230-236.
4. Wald N.J., Watt H.C., Law M.R., Weir D.G., McPartlin J., Scott J.M. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch. Intern. Med. 158:1998;862-867.
5. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
6. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Palma-Reis R.J., Boers G.H., Sheahan R.G., Israelsson B., Uiterwaal C.S., Meleady R., McMaster D., Verhoef P., Witteman J., Rubba P., Bellet H., Wautrecht J.C., de Valk H.W., Sales Luis A.C., Parrot-Rouland F.M., Tan K.S., Higgins I., Garcon D., Andria G.et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277:1997;1775-1781.
7. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:1987;10098-10103.
8. Parthasarathy S. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim. Biophys. Acta. 917:1987;337-340.
9. Heinecke J.W., Kawamura M., Suzuki L., Chait A. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J. Lipid Res. 34:1993;2051-2061.
10. Sparrow C.P., Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34:1993;1219-1228.
11. Hirano K., Ogihara T., Miki M., Yasuda H., Tamai H., Kawamura N., Mino M. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Radic. Res. 21:1994;267-276.
12. Jones B.G., Rose F.A., Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis. 105:1994;165-170.
13. Lupo E., Weisser B., Locher R., Vetter W. Homozystein induziert die oxidation des low density lipoproteins. Nieren - Hochdruckkr. 24:1995;S26-S27.
14. Schnitzer E., Pinchuk I., Fainaru M., Schafer Z., Lichtenberg D. Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochem. Biophys. Res. Commun. 216:1995;854-861.
15. Voutilainen S., Morrow J.D., Roberts L.J. II, Alfthan G., Alho H., Nyyssonen K., Salonen J.T. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler. Thromb. Vasc. Biol. 19:1999;1263-1266.
16. Blom H.J., Kleinveld H.A., Boers G.H., Demacker P.N., Hak-Lemmers H.L., Te Poele-Pothoff M.T., Trijbels J.M. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur. J. Clin. Investig. 25:1995;149-154.
17. Dudman N.P., Wilcken D.E., Stocker R. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis. Arterioscler. Thromb. 13:1993;512-516.
18. Ferguson E., Hogg N., Antholine W.E., Joseph J., Singh R.J., Parthasarathy S., Kalyanaraman B. Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications. Free Radic. Biol. Med. 26:1999;968-977.
19. Mansoor M.A., Guttormsen A.B., Fiskerstrand T., Refsum H., Ueland P.M., Svardal A.M. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clin. Chem. 39:1993;980-985.
20. Graham A. Cellular thiol production and oxidation of low-density lipoprotein. Free Radic. Res. 28:1998;611-621.
21. Lynch S.M., Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL. J. Biol. Chem. 270:1995;5158-5163.
22. Halvorsen B., Brude I., Drevon C.A., Nysom J., Ose L., Christiansen E.N., Nenseter M.S. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J. Lipid Res. 37:1996;1591-1600.
23. Cathcart M.K., McNally A.K., Chisolm G.M. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid Res. 32:1991;63-70.
24. Cotton F.A., Wilkinson G. Advanced Inorganic Chemistry. 5th ed. 1988;Wiley, New York.
25. Quintiliani M., Badiello R., Tamba M., Esfandi A., Gorin G. Radiolysis of glutathione in oxygen-containing solutions of pH 7. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 32:1977;195-202.
26. Schoneich C., Dillinger U., von Bruchhausen F., Asmus K.D. Oxidation of polyunsaturated fatty acids and lipids through thiyl and sulfonyl radicals: reaction kinetics, and influence of oxygen and structure of thiyl radicals. Arch. Biochem. Biophys. 292:1992;456-467.
27. Burkitt M.J. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch. Biochem. Biophys. 394:2001;117-135.
28. Esterbauer H., Puhl H., Dieber-Rotheneder M., Waeg G., Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23:1991;573-581.
29. Pinchuk I., Schnitzer E., Lichtenberg D. Kinetic analysis of copper-induced peroxidation of LDL. Biochim. Biophys. Acta. 15:1998;155-172.
30. Lynch S.M., Campione A.L., Moore M.K. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta. 6:2000;11-22.
31. McDowell I.F., McEneny J., Trimble E.R. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann. Clin. Biochem. 32:1995;167-174.
32. Graham J.M., Higgins J.A., Gillott T., Taylor T., Wilkinson J., Ford T., Billington D. A novel method for the rapid separation of plasma lipoproteins using self-generating gradients of iodixanol. Atherosclerosis. 124:1996;125-135.
33. Hallberg L., Sandstrom B., Aggett P.F. Iron, zinc and other trace elements. Garrow J.S., James W.P.T. Human Nutrition and Dietetics. 9th ed. 1996;195 Churchill Livingstone, Edinburgh.
34. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
35. Duerre J.A., Miller C.H. Preparation of L-homocysteine from L-homocysteine thiolactone. Anal. Biochem. 17:1966;310-315.
36. Gans P., Sabatini A., Vacca A. Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. Talanta. 43:1996;1739-1753.
37. Schnitzer E., Pinchuk I., Bor A., Fainaru M., Samuni A.M., Lichtenberg D. Lipid oxidation in unfractionated serum and plasma. Chem. Phys. Lipids. 92:1998;151-170.
38. Gurr M. Fats. Garrow J.S., James W.P.T. Human Nutrition and Dietetics. 9th ed. 1996;77-102 Churchill Livingstone, Edinburgh.
39. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
40. Ueland P.M., Mansoor M.A., Guttormsen A.B., Muller F., Aukrust P., Refsum H., Svardal A.M. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - a possible element of the extracellular antioxidant defense system. J. Nutr. 126:1996;1281S-1284S.
41. Mansoor M.A., Svardal A.M., Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 200:1992;218-229.
42. Perrin D.D. Stability Constants of Metal-Ion Complexes. Part B: Organic Ligands. 1979;Pergamon, Oxford.
43. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Morita H., Hiyamuta S., Ikeda S., Shimizu N., Yanagisawa N. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9:1995;267-272.
44. Schnitzer E., Pinchuk I., Bor A., Fainaru M., Lichtenberg D. The effect of albumin on copper-induced LDL oxidation. Biochim. Biophys. Acta. 18:1997;300-311.
45. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
46. Abuja P.M., Albertini R., Esterbauer H. Simulation of the induction of oxidation of low-density lipoprotein by high copper concentrations: evidence for a nonconstant rate of initiation. Chem. Res. Toxicol. 10:1997;644-651.
47. Girotti A.W. Mechanisms of lipid peroxidation. Free Radic. Biol. Med. 1:1985;87-95.
48. Schnitzer E., Fainaru M., Lichtenberg D. Oxidation of low density lipoprotein upon sequential exposure to copper ions. Free Radic. Res. 23:1995;137-149.
49. Santanam N., Parthasarathy S. Cellular cysteine generation does not contribute to the initiation of LDL oxidation. J. Lipid Res. 36:1995;2203-2211.
50. Lynch S.M., Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta. 1:1997;215-221.
51. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U. S. A. 81:1984;3883-3887.
52. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinaemia; an independent risk factor for vascular disease. New Engl. J. Med. 324:1991;1149-1155.
53. Mukhopadhyay C.K., Fox P.L. Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant. Biochemistry. 37:1998;14222-14229.
54. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
55. Raitakari O.T., Pitkanen O.P., Lehtimaki T., Lahdenpera S., Iida H., Yla-Herttuala S., Luoma J., Mattila K., Nikkari T., Taskinen M.R., Viikari J.S., Knuuti J. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J. Am. Coll. Cardiol. 30:1997;97-102.
56. Sengupta S., Chen H., Togawa T., DiBello P.M., Majors A.K., Budy B., Ketterer M.E., Jacobsen D.W. Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine. J. Biol. Chem. 276:2001;30111-30117.
57. Sengupta S., Wehbe C., Majors A.K., Ketterer M.E., DiBello P.M., Jacobsen D.W. Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation. J. Biol. Chem. 76:2001;46896-46904.